After hosting an open casting in May, Lionsgate revealed a Floridian was crowned the victor. Who is Devon Singletary and what ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the SCD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback